New Delhi: The Indian pharma sector's December-quarter revenue is estimated to remain flat, while profits are likely to slip owing to decline in US businesses and a sharp appreciation in rupee, says a report. According to an Edelweiss Securities report, though the October-December quarter was “action ...
Read more: Pharma sector earnings to remain muted on weak US business, strong rupee